First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes.
Elizarova
E P
EP
Cardiology Research Center, Moscow, Russia.
Nedosugova
L V
LV
D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008780:Methyltransferases / Q000097:blood; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D013654:Taurine / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007004:Hypoglycemic Agents; D007328:Insulin; D010743:Phospholipids; D014280:Triglycerides; D013654:Taurine; D002784:Cholesterol; D008780:Methyltransferases